It was a privilege and pleasure to partner once again with Adocia to secure the appointments of Katherine Bowdish, PhD, Claudia Mitchell, and Stephane Boissel as Independent Directors to their Board. Congrats Adocia !

Adocia is a clinical-stage biotechnology company that specializes in the development of innovative formulations of therapeutic proteins and peptides for the treatment of diabetes and metabolic diseases.

See publication on LinkedIn: https://www.linkedin.com/posts/mccabeelizabeth_biotech-innovate-business-activity-6805883549011574784-bZtC